New observations on factor XI deficiency
Authors:
- 8 October 2004
- journal article
- Published by Wiley in Haemophilia
- Vol. 10 (s4) , 184-187
Abstract
Summary. Factor (F) XI is an injury‐related bleeding tendency that commonly occurs when trauma involves tissues rich in fibronolytic activators. Severe FXI deficiency is defined when the activity of FXI in plasma is less than 15 U dL−1. The disorder is inherited as an autosomal recessive trait manifesting in homozygotes or compound heterozygotes, and infrequently in heterozygotes. So far 53 mutations in the gene of FXI have been described and four of them were found to be prevalent in Ashkenazi Jews, Iraqi Jews, Basques or the English population. For each of the four mutations a founder effect was discerned. Inhibitors can develop in patients with FXI level < 1U dL−1 who were exposed to plasma which seriously complicates their management during surgery. No correction of a prolonged aPTT by normal plasma is indicative of the presence of an inhibitor. In contrast to patients with haemophilia A, severe FXI deficiency provides no protection against myocardial infarction. In patients with severe FXI deficiency undergoing surgery, fresh frozen plasma is the treatment of choice. FXI concentrates can also be used but cause thrombosis in approximately 10% of patients, particularly those with cardiovascular disease. Recombinant FVIIa has successfully prevented bleeding during or after surgery in patients with FXI inhibitors.Keywords
This publication has 22 references indexed in Scilit:
- Dominant factor XI deficiency caused by mutations in the factor XI catalytic domainBlood, 2004
- The first yearJournal of Thrombosis and Haemostasis, 2004
- Hemostasis during Normal Pregnancy and PuerperiumSeminars in Thrombosis and Hemostasis, 2003
- Prevalence, causes, and characterization of factor XI inhibitors in patients with inherited factor XI deficiencyBlood, 2003
- Factor XI deficiency presenting in pregnancy: diagnosis and managementBJOG: An International Journal of Obstetrics & Gynaecology, 2002
- Factor XI deficiency and its managementHaemophilia, 2000
- Dental surgery in patients with severe factor XI deficiency without plasma replacementBlood Coagulation & Fibrinolysis, 1992
- Factor XI Deficiency in Ashkenazi Jews in IsraelNew England Journal of Medicine, 1991
- Factor VIIa in the treatment of haemophiliaBlood Coagulation & Fibrinolysis, 1990
- Factor XI gene (F11) is located on the distal end of the long arm of human chromosome 4Cytogenetic and Genome Research, 1989